Femi Kuti net worth
Quick answer
Femi Kuti's estimated net worth is $34.0M (range $23.8M – $51.0M) as of 2026. Femi Kuti is CEO at Reliance Health. Reliance Health valuation.
Femi Kuti is CEO at Reliance Health (YC W17). Independent Entrepreneurial Check model estimate from public YC data.
At a glance
- Company status: Active
- Background: Nigerian
- Education: Yale University
- Region: Nigeria
- Industries: Healthcare, Healthcare Services
- Team size: 384
- Website: https://www.getreliancehealth.com
Who is Femi Kuti?
Femi Kuti is a Nigerian entrepreneur and one of the founders of Reliance Health, a healthcare company based in Nigeria.
Highlights:
- Yale University
- Reliance Health
- Y Combinator
Background
Publicly described labels for Femi Kuti: Nigerian. Heritage/background labels may be inferred and are not verified identity documents.
About Reliance Health
Reliance Health uses technology to make quality healthcare delightful, affordable and accessible in emerging markets. Through an integrated approach that includes affordable health insurance, telemedicine and a combination of partner and proprietary healthcare facilities, Reliance Health offers innovative healthcare solutions that meet the needs of emerging markets including Nigeria, Egypt and growing
FAQ: Femi Kuti net worth and Reliance Health valuation
What is Femi Kuti's net worth?
Femi Kuti's estimated net worth is $34.0M (range $23.8M – $51.0M) as of 2026. Femi Kuti is CEO at Reliance Health. Entrepreneurial Check publishes an independent model-based estimate from public company and role data. Not verified net worth, and Entrepreneurial Check is not affiliated with Y Combinator or the profiled companies.
What is Reliance Health valuation?
Reliance Health's estimated valuation on Entrepreneurial Check is $400.0M. That valuation, or a disclosed round when one is public, is the source for the paper-wealth estimate. Independent model output — not a verified appraisal or official mark.
What is Femi Kuti's role?
Femi Kuti is CEO at Reliance Health, a Y Combinator-backed startup (batch W17).